ATE349458T1 - Etonogestrelester - Google Patents

Etonogestrelester

Info

Publication number
ATE349458T1
ATE349458T1 AT03735713T AT03735713T ATE349458T1 AT E349458 T1 ATE349458 T1 AT E349458T1 AT 03735713 T AT03735713 T AT 03735713T AT 03735713 T AT03735713 T AT 03735713T AT E349458 T1 ATE349458 T1 AT E349458T1
Authority
AT
Austria
Prior art keywords
etonogestrelester
Prior art date
Application number
AT03735713T
Other languages
English (en)
Inventor
Nijs Henrik De
Der Voort Hendrikus Adrian Van
Dirk Leysen
Arij Jan Grootenhuis
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of ATE349458T1 publication Critical patent/ATE349458T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
AT03735713T 2002-05-30 2003-05-22 Etonogestrelester ATE349458T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02077119 2002-05-30

Publications (1)

Publication Number Publication Date
ATE349458T1 true ATE349458T1 (de) 2007-01-15

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03735713T ATE349458T1 (de) 2002-05-30 2003-05-22 Etonogestrelester

Country Status (31)

Country Link
US (1) US7323454B2 (de)
EP (1) EP1513861B1 (de)
JP (1) JP4716726B2 (de)
KR (1) KR20050009723A (de)
CN (2) CN101100480A (de)
AR (1) AR040130A1 (de)
AT (1) ATE349458T1 (de)
AU (1) AU2003238081B2 (de)
BR (1) BR0311254A (de)
CA (1) CA2487722C (de)
CO (1) CO5631449A2 (de)
DE (1) DE60310714T2 (de)
DK (1) DK1513861T3 (de)
ES (1) ES2277085T3 (de)
HK (1) HK1072609A1 (de)
HR (1) HRP20041101A2 (de)
IL (1) IL165087A0 (de)
IS (1) IS2421B (de)
MX (1) MXPA04011797A (de)
NO (1) NO20044898L (de)
NZ (1) NZ536619A (de)
PE (1) PE20040068A1 (de)
PL (1) PL373855A1 (de)
PT (1) PT1513861E (de)
RS (1) RS97604A (de)
RU (1) RU2325910C2 (de)
SI (1) SI1513861T1 (de)
TW (1) TW200403065A (de)
UA (1) UA80126C2 (de)
WO (1) WO2003102012A2 (de)
ZA (1) ZA200410410B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
US20090062909A1 (en) 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
EP1909973B1 (de) 2005-07-15 2018-08-22 Micell Technologies, Inc. Polymer-überzüge mit einem arzneipulver mit kontrollierter morphologie
US8852625B2 (en) 2006-04-26 2014-10-07 Micell Technologies, Inc. Coatings containing multiple drugs
JP5603598B2 (ja) 2007-01-08 2014-10-08 ミセル テクノロジーズ、インコーポレイテッド 生物分解層を有するステント
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
WO2009146209A1 (en) 2008-04-17 2009-12-03 Micell Technologies, Inc. Stents having bioabsorbable layers
AU2009270849B2 (en) 2008-07-17 2013-11-21 Micell Technologies, Inc. Drug delivery medical device
WO2010111232A2 (en) 2009-03-23 2010-09-30 Micell Technologies, Inc. Drug delivery medical device
CN102481195B (zh) 2009-04-01 2015-03-25 米歇尔技术公司 涂覆支架
WO2010121187A2 (en) 2009-04-17 2010-10-21 Micell Techologies, Inc. Stents having controlled elution
EP2453834A4 (de) 2009-07-16 2014-04-16 Micell Technologies Inc Medizinische wirkstofffreisetzungsvorrichtung
EP2531140B1 (de) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent und stenteinsatzsystem mit verbesserter einsetzbarkeit
US10232092B2 (en) 2010-04-22 2019-03-19 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
CA2805631C (en) 2010-07-16 2018-07-31 Micell Technologies, Inc. Drug delivery medical device
US10117972B2 (en) 2011-07-15 2018-11-06 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
CA2905419C (en) 2013-03-12 2020-04-28 Micell Technologies, Inc. Bioabsorbable biomedical implants
WO2014186532A1 (en) 2013-05-15 2014-11-20 Micell Technologies, Inc. Bioabsorbable biomedical implants
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB8313921D0 (en) 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
BR9408457A (pt) * 1993-12-27 1997-08-05 Akzo Nobel Nv Preparação farmacêutica percutânia
DE19613698A1 (de) 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
WO1997003709A1 (de) 1995-07-17 1997-02-06 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel
US6437158B1 (en) 1998-06-19 2002-08-20 Akzo Nobel N.V. Testosterone derivative
WO1999067270A1 (en) 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
US6180682B1 (en) 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Also Published As

Publication number Publication date
US20050222113A1 (en) 2005-10-06
WO2003102012A3 (en) 2004-04-22
CN1314701C (zh) 2007-05-09
NO20044898L (no) 2005-02-25
WO2003102012A9 (en) 2005-01-13
WO2003102012A2 (en) 2003-12-11
SI1513861T1 (sl) 2007-06-30
IS2421B (is) 2008-10-15
DK1513861T3 (da) 2007-04-10
JP2005532350A (ja) 2005-10-27
JP4716726B2 (ja) 2011-07-06
HRP20041101A2 (en) 2004-12-31
ZA200410410B (en) 2006-02-22
RS97604A (en) 2006-10-27
ES2277085T3 (es) 2007-07-01
MXPA04011797A (es) 2005-03-31
AR040130A1 (es) 2005-03-16
NZ536619A (en) 2007-09-28
CN101100480A (zh) 2008-01-09
PT1513861E (pt) 2007-03-30
RU2004138807A (ru) 2005-05-27
IS7528A (is) 2004-11-15
BR0311254A (pt) 2005-03-15
IL165087A0 (en) 2005-12-18
CA2487722C (en) 2011-07-19
DE60310714T2 (de) 2007-10-11
CO5631449A2 (es) 2006-04-28
PE20040068A1 (es) 2004-02-18
EP1513861A2 (de) 2005-03-16
AU2003238081A1 (en) 2003-12-19
KR20050009723A (ko) 2005-01-25
HK1072609A1 (en) 2005-09-02
CN1692122A (zh) 2005-11-02
DE60310714D1 (de) 2007-02-08
EP1513861B1 (de) 2006-12-27
AU2003238081B2 (en) 2008-09-18
TW200403065A (en) 2004-03-01
RU2325910C2 (ru) 2008-06-10
PL373855A1 (en) 2005-09-19
CA2487722A1 (en) 2003-12-11
UA80126C2 (en) 2007-08-27
US7323454B2 (en) 2008-01-29

Similar Documents

Publication Publication Date Title
ATE457980T1 (de) Aryloxime
ATE534648T1 (de) C-6-modifizierte indazolylpyrrolotriazine
DE50305852D1 (de) Einspritzventil
DE50306589D1 (de) Wischblatt
ATE318817T1 (de) Aza-arylpiperazine
ATE427876T1 (de) Luftkissenboot
DE50212360D1 (de) Anfahrhilfesteuerungsvorrichtung
DE50212349D1 (de) Hirurgie
DE50301200D1 (de) Wischblatt
ATE349458T1 (de) Etonogestrelester
DE50305301D1 (de) Einspritzventil
DE50309536D1 (de) Fadenabsaugvorrichtung
ATA1572002A (de) Managementspleisskassette
DE50301960D1 (de) Hydrolager
DE50307971D1 (de) Gelenklager
DE50302660D1 (de) Stopfmachine
DE50309499D1 (de) Librierwerkzeugen
DE50301464D1 (de) Schraubensicherung
ATA4142004A (de) Trägerverbau
DE50305973D1 (de) Auffangwanne
ATE469773T1 (de) Zugöse
DE50307628D1 (de) Getraenkehalter
DE50303317D1 (de) Einschub-leistungsschalter
DE50308979D1 (de) Einspritzventil
ATE396192T1 (de) N-sulfonylaminothiazole

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1513861

Country of ref document: EP

REN Ceased due to non-payment of the annual fee